Publication:
In Obese Patients With Type 2 Diabetes, Mast Cells in Omental Adipose Tissue Decrease the Surface Expression of CD45, CD117, CD203c, and FcϵRI.

Loading...
Thumbnail Image

Date

2022-02-14

Authors

Lopez-Perez, David
Redruello-Romero, Anaïs
Garcia-Rubio, Jesus
Arana, Carlos
Garcia-Escudero, Luis A
Tamayo, Francisco
Salmeron, Javier
Galvez, Julio
Leon, Josefa
Carazo, Angel

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Frontiers Research Foundation
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The paradigm of mast cells in type 2 diabetes is changing. Although they were first considered deleterious inflammatory cells, now they seem to be important players driving adipose tissue homeostasis. Here we have employed a flow cytometry-based approach for measuring the surface expression of 4 proteins (CD45, CD117, CD203c, and FcϵRI) on mast cells of omental (o-WAT) and subcutaneous white adipose tissue (s-WAT) in a cohort of 96 patients with morbid obesity. The cohort was split into three groups: non-T2D, pre-T2D, and T2D. Noteworthy, patients with T2D have a mild condition (HbA1c

Description

MeSH Terms

Adipose Tissue
Diabetes Mellitus, Type 2
Humans
Leukocyte Common Antigens
Mast Cells
Obesity, Morbid
Phosphoric Diester Hydrolases
Proto-Oncogene Proteins c-kit
Pyrophosphatases
Receptors, IgE

DeCS Terms

Antígenos comunes de leucocito
Diabetes Mellitus tipo 2
Hidrolasas diéster fosfóricas
Humanos
Mastocitos
Obesidad mórbida
Pirofosfatasas
Proteínas Proto-oncogénicas c-kit
Receptores de IgE
Tejido adiposo

CIE Terms

Keywords

adipose tissue, bariatric surgery, flow cytometry, mast cell, obesity, type 2 diabetes

Citation

Lopez-Perez D, Redruello-Romero A, Garcia-Rubio J, Arana C, Garcia-Escudero LA, Tamayo F, et al. In Obese Patients With Type 2 Diabetes, Mast Cells in Omental Adipose Tissue Decrease the Surface Expression of CD45, CD117, CD203c, and FcϵRI. Front Endocrinol (Lausanne). 2022 Mar 15;13:818388.